Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shyam Srinivasan

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Pediatric Blood & Cancer|December 15, 2024
Transforming Pediatric Oncology Research: The Role of Collaboration, Precision Medicine, and Evolving Study DesignsShyam Srinivasan
Hematological Oncology|January 3, 2025
Childhood ALL and Asparaginase Intensification: Are We at the Brink?Shyam Srinivasan
Pediatric Blood & Cancer|January 9, 2023
Is it time to move toward a more Bayesian approach for clinical studies in childhood cancer?Shyam Srinivasan
Hematological Oncology|August 7, 2024
From trials to statistical insights: Bortezomib's story in childhood T-cell lymphoid malignanciesShyam Srinivasan
Ejhaem|October 17, 2024
Dasatinib in core-binding factor acute myeloid leukemia: A promising therapeutic approachShyam Srinivasan
Leukemia & Lymphoma|August 1, 2022
Optimal dosing of cytarabine in childhood acute myeloid leukemia: do we have the answer yet?Shyam Srinivasan
Leukemia|March 29, 2024
Mitigating immortal-time bias: exploring osteonecrosis and survival in pediatric ALL - AALL0232 trial insightsShyam Srinivasan, Swaminathan Keerthivasagam
South Asian Journal of Cancer|December 25, 2025
Minimal Disseminated Disease Continues to Impact Outcomes Even in the Era of Targeted Therapy in Childhood ALK+ Anaplastic Large Cell Lymphoma, What More Do We Have to Offer?Nidhi Dhariwal, Shyam Srinivasan
Journal of Pediatric Hematology/Oncology|May 8, 2024
Transforming Childhood AML Care in IndiaShyam Srinivasan, Swaminathan Keerthivasagam
American Journal of Blood Research|March 25, 2026
Venetoclax-based low-intensity therapy in pediatric AML: A viable option for chemotherapy-intolerant patientsNidhi Dhariwal, Shyam Srinivasan
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Pediatric Blood & Cancer|December 15, 2024
Transforming Pediatric Oncology Research: The Role of Collaboration, Precision Medicine, and Evolving Study DesignsShyam Srinivasan
Hematological Oncology|January 3, 2025
Childhood ALL and Asparaginase Intensification: Are We at the Brink?Shyam Srinivasan
Pediatric Blood & Cancer|January 9, 2023
Is it time to move toward a more Bayesian approach for clinical studies in childhood cancer?Shyam Srinivasan
Hematological Oncology|August 7, 2024
From trials to statistical insights: Bortezomib's story in childhood T-cell lymphoid malignanciesShyam Srinivasan
Ejhaem|October 17, 2024
Dasatinib in core-binding factor acute myeloid leukemia: A promising therapeutic approachShyam Srinivasan
Leukemia & Lymphoma|August 1, 2022
Optimal dosing of cytarabine in childhood acute myeloid leukemia: do we have the answer yet?Shyam Srinivasan
Leukemia|March 29, 2024
Mitigating immortal-time bias: exploring osteonecrosis and survival in pediatric ALL - AALL0232 trial insightsShyam Srinivasan, Swaminathan Keerthivasagam
South Asian Journal of Cancer|December 25, 2025
Minimal Disseminated Disease Continues to Impact Outcomes Even in the Era of Targeted Therapy in Childhood ALK+ Anaplastic Large Cell Lymphoma, What More Do We Have to Offer?Nidhi Dhariwal, Shyam Srinivasan
Journal of Pediatric Hematology/Oncology|May 8, 2024
Transforming Childhood AML Care in IndiaShyam Srinivasan, Swaminathan Keerthivasagam
American Journal of Blood Research|March 25, 2026
Venetoclax-based low-intensity therapy in pediatric AML: A viable option for chemotherapy-intolerant patientsNidhi Dhariwal, Shyam Srinivasan
Pageof 6